Tested Applications
| Positive WB detected in | HepG2 cells, HeLa cells |
| Positive IHC detected in | human urothelial carcinoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:250-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10131-1-AP targets FUSIP1/SRS10 in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0176 Product name: Recombinant human FUSIP1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 9-183 aa of BC001107 Sequence: NTSLFVRNVADDTRSEDLRREFGRYGPIVDVYVPLDFYTRRPRGFAYVQFEDVRDAEDALHNLDRKWICGRQIEIQFAQGDRKTPNQMKAKEGRNVYSSSRYDDYDRYRRSRSRSYERRRSRSRSFDYNYRRSYSPRNSRPTGRPRRSRSHSDNDRPNCSWNTQYSSAYYTSRKI Predict reactive species |
| Full Name | FUS interacting protein (serine/arginine-rich) 1 |
| Calculated Molecular Weight | 22 kDa |
| Observed Molecular Weight | 31 kDa |
| GenBank Accession Number | BC001107 |
| Gene Symbol | FUSIP1 |
| Gene ID (NCBI) | 10772 |
| RRID | AB_2877726 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O75494 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
FUSIP1, also named as SRS10, or TASR, is a 262 amino acid protein, which belongs to the splicing factor SR family. FUSIP1 as a Splicing factor that in its dephosphorylated form acts as a general repressor of pre-mRNA splicing. FUSIP1 is required for splicing repression in M-phase cells and after heat shock and also acts as a splicing factor that specifically promotes exon skipping during alternative splicing. FUSIP1 Interacting with YTHDC1, a RNA-binding protein that recognizes and binds N6-methyladenosine (m6A)-containing RNAs, prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing.
Publications
What published studies show
The FUSIP1/SRS10 Polyclonal antibody (catalog no. 10131-1-AP) has 4 total citations. These appear in Nature Communications, Molecular Cell, Journal of Experimental & Clinical Cancer Research, and Proteomics Clinical Applications. The associated research fields include splicing factor regulation of tumor growth, DNA replication stress and PARP inhibitor resistance in prostate cancer, glioma angiogenesis, and bladder cancer diagnostic markers. All citations used the antibody in human samples, primarily for Western blot, with one also applying immunohistochemistry.
| Species | Application | Title |
|---|---|---|
Nat Commun Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth. | ||
Mol Cell Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancer. | ||
J Exp Clin Cancer Res SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.
| ||
Proteomics Clin Appl Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer |









